Methyl 5-Fluoro-4-methoxy-3-(trifluoromethyl)benzoate, 98%, 250mg

Tri(p-tolyl)phosphine>96.0%(GC)5g

Lithium 4-methyl-1-(pyridin-2-yl)-2,6,7-trioxa-1-borabicyclo[2.2.2]octan-1-uide, 95.0%, 5g

2,4,5-Trifluoronitrobenzene>98.0%(GC)5g

D-Leucine>98.0%(T)25g

(R)-3-(1-aminoethyl)-5-(trifluoromethyl)aniline hydrochloride, 98%, 5g

4-allyl-5-(5-chloro-2-methoxyphenyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

2,2,2-Trifluoroacetic acid- 2-bromoethyl ester, 25g

N,N-Dicyclohexylcarbodiimide (DCC), 100 g, >=98%, glass packaging

tert-butyl 3-(aminomethyl)-1H-indole-1-carboxylate, 95.0%, 100mg

2-Iodopropane (stabilized with Copper chip)>99.0%(GC)500g

4-ethyl-5-(4-isopropylphenyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 5.00 µm, 1 Piece(s)